Bliss GVS Pharma Hits Fresh ATH After ₹728 Breakout

Bliss GVS Pharma hits a fresh all-time high at ₹737.65 after breaking ₹728 resistance. The stock has gained around 347% in CY2026, reflecting strong momentum. Bliss GVS Pharma Ltd. (

) hits a fresh all-time high at ₹737.65 after breaking ₹728 resistance. The stock has gained around 347% in CY2026, reflecting strong momentum. Bliss GVS Pharma Ltd. remained in the spotlight after the stock hit the 5% upper circuit and closed at ₹737.65, gaining 4.68% or ₹32.95 in the session on 28 Sept 2026. The stock also marked a fresh all-time high, extending its price momentum. From a technical perspective, the stock continues to display a strongly bullish trend. After a period of decent consolidation near the top, BLISSGVS broke above the key resistance zone of ₹728 and closed above that level, marking a notable breakout. The stock's price performance in CY2026 has been particularly striking, with gains of around 347% so far. Bliss GVS Pharma operates globally across 60+ countries and has a strong presence in pharmaceutical formulations, particularly suppositories and pessaries. With the stock at ₹737.65, above its previous ₹728 resistance and at a fresh all-time high, BLISSGVS is currently witnessing a strong bull run. The breakout above ₹728 came after a period of consolidation, adding significance to the latest price move. The price action remains the key feature of the stock's current market setup. Disclosure: I do not hold any position or have any financial interest in the mentioned stock.